Normalization of intrarenal blood flow after surgical treatment of aortic insufficiency caused by valve dysplasia and infective endocarditis
Abstract
The authors noted significant impairment of intrarenal blood flow with almost complete cessation of the diastolic component of blood flow in the renal parenchyma in 51-year-old patient with
IV grade aortic insufficiency. Successful aortic valve replacement in combination with mammary
bypass surgery in cardiopulmonary bypass and cold cardioplegia allowed to normalize not only intracardiac, but renal hemodynamics also. Gemodialysis in the postoperative period is not required.
No specific complications were registered in the postoperative period.
Keywords:secondary cardiomyopathy, aortic insufficiency, renal failure, diastolic renal blood flow
Clin. Experiment. Surg. Petrovsky J. 2017; 5 (2): 66–71.
DOI: 10.24411/2308-1198-2017-00035
Received: 01.04.2017. Accepted: 19.04.2017.
References
1. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney
disease as a risk factor for development of cardiovascular disease:
a statement from the American Heart Association Councils on Kidney
in Cardiovascular Disease, High Blood Pressure Research, Clinical
Cardiology, and Epidemiology and Prevention. Circulation. 2003;
108: 2154–69.
2. London G.M., Pannier B., Marchais S.J., et al. Calcification
of the aortic valve in the dialyzed patient. J Am Soc Nephrol. 2000;
11: 778–83.
3. Mukhin A.N., Fomin V.V. The kidney in hypertensive disease
(hypertensive nephropathy). In: E.I. Chazov, I.E. Chasovoy (eds). Manual of Hypertension. Moscow: Media Medika, 2005: 265–89.
(in Russian)
4. Thourani V., Keelling B., Sarin E.L. et al. Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement // Ann. Thorac. Surg. 2011. Vol. 91. P. 1798-1807.
5. Sadovnikov V.I. Intraorganic blood circulation of the kidney
in the diagnosis of post-transplant complications: Diss. Moscow,
1998. (in Russian)
6. Arkadiusz L., Kade G., Niemczyk S. Renal resistive index as
a marker of vascular damage in cardiovascular diseases. Int Urol
Nephrol. 2014; 46 (2): 395–402.